Literature DB >> 12904710

Cancer in interstitial pulmonary fibrosis and sarcoidosis.

Om P Sharma1, Carla Lamb.   

Abstract

The occurrence of lung cancer in patients with diffuse interstitial pulmonary disease is well-known. The incidence, however, varies and ranges from 9.8 to 38%. The pathogenesis of lung cancer in pulmonary fibrosis is unclear, but genetic as well as environmental factors seem to be involved.

Entities:  

Mesh:

Year:  2003        PMID: 12904710     DOI: 10.1097/00063198-200309000-00010

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

Review 1.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

2.  Risk of Malignancy Among Patients With Sarcoidosis: A Population-Based Cohort Study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-16       Impact factor: 4.794

Review 3.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.